ID   KSCBi005-A-10
AC   CVCL_C9DA
SY   hiPSC-HIF-1alphaKO; hiPSC-HIF1alphaKO; hiPSC-HIF1aKO
DR   hPSCreg; KSCBi005-A-10
DR   Wikidata; Q123032856
RX   PubMed=38636267;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4910; HIF1A.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Hematopoietic cell; CL=CL_1001610.
ST   Source(s): PubMed=38636267
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 9,14
ST   D18S51: 11,14
ST   D21S11: 29,32.2
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D7S820: 11,12
ST   D8S1179: 11,12
ST   FGA: 21,25
ST   Penta D: 9,12
ST   Penta E: 17,18
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR10 ! CMC-hiPSC-003
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
RX   PubMed=38636267; DOI=10.1016/j.scr.2024.103415;
RA   Han H.-J., Kim J.-H.;
RT   "KSCBi005-A-10 (hiPSC-HIF1alphaKO), a HIF1alpha knockout human induced
RT   pluripotent stem cell line, for demonstrating the role of cellular
RT   response to hypoxia.";
RL   Stem Cell Res. 77:103415-103415(2024).
//